Mark Davis

From MEpedia, a crowd-sourced encyclopedia of ME and CFS science and history

Mark M. Davis, PhD, is a Professor of Microbiology and Immunology and the Director of the Stanford Institute for Immunity, Transplantation and Infection at Stanford University School of Medicine.[1] He is on the ME/CFS Advisory Board of the Stanford ME/CFS Initiative.[2]

Education[edit | edit source]

  • Ph.D., Caltech, Molecular Biology (1981)
  • B.A., The Johns Hopkins University, Molecular Biology (1974)

ME/CFS research[edit | edit source]

Professor Mark Davis, along with Dr. Jose Montoya and many colleagues from several universities, are involved with the study of cytokines as a potential diagnostic biomarker of ME/CFS disease severity[3], as well as, differentiating between ME/CFS patients and sedentary controls.[4]

Notable studies on ME/CFS[edit | edit source]

Talks and interviews[edit | edit source]

Learn more[edit | edit source]

Mark Davis Stanford Bio

See also[edit | edit source]

References[edit | edit source]

  3. Chronic fatigue syndrome research at Stanford - Stanford Medicine Spring 2016 - By: Kris Newby
  4. 4.0 4.1 Moneghetti, Kegan J.; Skhiri, Mehdi; Contrepois, Kévin; Kobayashi, Yukari; Maecker, Holden T.; Davis, Mark M.; Snyder, Michael; Haddad, Francois; Montoya, Jose G. (2018), "Value of Circulating Cytokine Profiling During Submaximal Exercise Testing in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome", Scientific Reports, 8, doi:10.1038/s41598-018-20941-w
  5. Montoya, Jose G.; Holmes, Tyson H.; Anderson, Jill N.; Maecker, Holden T.; Rosenberg-Hasson, Yael; Valencia, Ian J.; Chu, Lily; Younger, Jarred W.; Tato, Cristina M.; Davis, Mark M. (2017), "Cytokine signature associated with disease severity in chronic fatigue syndrome patients", Proceedings of the National Academy of Sciences of the United States of America, 114 (34): E7150-E7158, doi:10.1073/pnas.1710519114